Skip to main content

Protein based covid-19 vaccine

 

A protein-based COVID-19 vaccine that mimics the shape of the virus


Posted Today

Even as several safe and effective COVID-19 vaccines are being administered to people worldwide, scientists are still hard at work developing different vaccine strategies that could provide even stronger or longer-lasting immunity against SARS-CoV-2 and its variants.


Now, researchers reporting in ACS Central Science have immunized mice with nanoparticles that mimic SARS-CoV-2 by displaying multiple copies of the receptor binding domain (RBD) antigen, showing that the vaccine triggers robust antibody and T cell responses.



Although the first vaccines to receive Emergency Use Authorization by the U.S. Food and Drug Administration were based on mRNA, more conventional protein-based vaccines have also shown promise in clinical trials. Most train the immune system to recognize the RBD, a peptide that is the portion of the SARS-CoV-2 spike protein that binds to the ACE-2 receptor on host cell surfaces.


However, not all of these vaccines elicit both antibody and T cell responses, both of which are thought to be important for longer-lasting immunity. Melody Swartz, Jeffrey Hubbell and colleagues had previously developed a vaccine delivery tool called polymersomes –– self-assembling, spherical nanoparticles that can encapsulate antigens and adjuvants (helper molecules that boost the immune response) and then release them inside immune cells. Polymersomes trigger robust T cell immunity, and the researchers wondered if they could further improve the antibody response by engineering the nanoparticles to mimic viruses by displaying multiple copies of the RBD on their surfaces.


So the team made polymersomes that were similar in size to SARS-CoV-2 and decorated them with many RBDs. After characterizing the nanoparticles in vitro, they injected them into mice, along with separate polymersomes containing an adjuvant, in two doses that were three weeks apart. For comparison, they immunized another group of mice with polymersomes that encapsulated the RBD, along with the nanoparticles containing the adjuvant. Although both groups of mice produced high levels of RBD-specific antibodies, only the surface-decorated polymersomes generated neutralizing antibodies that prevented SARS-CoV-2 infection in cells.

Both the surface-decorated and encapsulated RBDs triggered robust T cell responses. Although the new vaccine still needs to be tested for safety and efficacy in humans, it could have advantages over mRNA vaccines with regard to widespread distribution in resource-limited areas, the researchers say. That’s because the surface-decorated polymersomes are stable and active for at least 6 months with refrigeration, in contrast to mRNA vaccines that require subzero temperature storage.



Comments

Anonymous said…
🥰🥰🥰
August 12, 2021 at 6:35 PM
Post a Comment

Popular posts from this blog

Feeling of smell is our most quick admonition framework

  Feeling of smell is our most quick admonition framework The capacity to recognize and respond to the smell of a potential danger is a precondition of our and other vertebrates' endurance. Utilizing an original strategy, scientists at Karolinska Institutet have had the option to concentrate on what occurs in the cerebrum when the focal sensory system passes judgment on a smell to address risk.  The review, which is distributed in PNAS, demonstrates that negative scents related with repulsiveness or disquiet are handled sooner than positive scents and trigger an actual aversion reaction.  Delineation by Behzad Iravani/Karolinska Institutet  "The human aversion reaction to disagreeable scents related with risk has for some time been viewed as a cognizant intellectual interaction, yet our review shows interestingly that it's oblivious and incredibly quick," says the concentrate's first creator Behzad Iravani, analyst at the Division of Clinical Neuroscience, Karolin...
Post a Comment
Read more

Uranium isotopes helps defending atomic material

  Fast identification of uranium isotopes helps defend atomic materials Scientific physicists at the Division of Energy's Oak Edge Public Research center have fostered a fast way of estimating isotopic proportions of uranium and plutonium gathered on natural swipes, which could help Global Nuclear Energy Organization investigators identify the presence of undeclared atomic exercises or material.  "This strategy expands on a business microextraction test to straightforwardly test solids and thusly remove the analytes from a surface and into a streaming arrangement," said ORNL's Benjamin Manard. He drove the confirmation of-idea study, which exhibited that this inspecting system was compelling at extricating actinide material (e.g., uranium and plutonium) from ecological swipes. The paper made the title page of the diary Logical Science.  ORNL logical physicists coupled a microextraction test to a mass spectrometer for estimation of uranium isotope proportions from natu...
Post a Comment
Read more

Nasa, ULA launch lucy mission to fossils 's of planet formation

  NASA, ULA Launch Lucy Mission to ‘Fossils’ of Planet Formation NASA’s Lucy mission, the agency’s first to Jupiter’s Trojan asteroids, launched at 5:34 a.m. EDT Saturday on a United Launch Alliance (ULA) Atlas V rocket from Space Launch Complex 41 at Cape Canaveral Space Force Station in Florida. Over the next 12 years, Lucy will fly by one main-belt asteroid and seven Trojan asteroids, making it the agency’s first single spacecraft mission in history to explore so many different asteroids. Lucy will investigate these “fossils” of planetary formation up close during its journey. A United Launch Alliance Atlas V rocket with the Lucy spacecraft aboard is seen in this 2 minute and 30 second exposure photograph as it launches from Space Launch Complex 41, Saturday, Oct. 16, 2021, at Cape Canaveral Space Force St
Post a Comment
Read more